Nathan Nagel has 22 years’ international experience in commercial medical companies with 14 years’ experience of being an executive director. He is currently the CEO of the Fratrem Group which includes OCS (Oncology Commercial Services), MEMP (Middle East Medical Portal) and CECS (Clinical Entrepreneur Commercial Services). He leads multiple global online medical networks including a global oncology network of over 50K members. He is a mentor to CEOs on the Cancer Research UK Technology accelerator and board Adviser to the Kings College breast cancer AI imaging company Elaitra Ltd. His past executive experience includes CEO at Gamlen Tableting Ltd (Pharmaceutical lab testing), Managing Director of Sanyal Bio LLC (Contract Research in Liver disease), CEO of Neuro-Bio Ltd (Neuroscience biotechnology company), CEO of Oncology Pharma Ltd (Market research company), and Managing partner of LifeScience Ventures Ltd (Venture Capital). Prior to leading companies Nathan worked in commercial roles for Bayer Diagnostics and Takeda Pharmaceuticals, where he started his career.